Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Royalty Pharma PLC (RPRX) had Receiveable Turnover of 83.97 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$2.26B |
|
$858.98M |
|
-- |
|
$2.26B |
|
$971.13M |
|
$1.29B |
|
$38.37M |
|
$1.33B |
|
$1.18B |
|
$1.33B |
|
$1.33B |
|
$1.33B |
|
$1.18B |
|
$1.29B |
|
$1.31B |
|
448.19M |
|
594.11M |
|
$1.92 |
|
$1.91 |
|
| Balance Sheet Financials | |
$1.80B |
|
$15.13B |
|
$16.42B |
|
$18.22B |
|
$1.25B |
|
$6.61B |
|
$6.63B |
|
$7.88B |
|
$10.34B |
|
$10.34B |
|
$10.34B |
|
981.42M |
|
| Cash Flow Statement Financials | |
$2.77B |
|
$-2.68B |
|
$361.14M |
|
$477.01M |
|
$929.03M |
|
$452.02M |
|
$2.34M |
|
$-863.90M |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
0.39 |
|
0.74 |
|
100.00% |
|
57.10% |
|
57.10% |
|
57.96% |
|
58.79% |
|
37.95% |
|
$2.75B |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
-- |
|
|
Receiveable Turnover |
83.97 |
4.35 |
|
12.87% |
|
12.87% |
|
7.30% |
|
7.85% |
|
$10.54 |
|
$4.63 |
|
$4.66 |
|